Results 31 to 40 of about 22,336 (265)
Gastrointestinal Endoscopy, 2016 Previous studies show that microendoscopic images can be interpreted visually to identify the presence of neoplasia in patients with Barrett's esophagus (BE), but this approach is subjective and requires clinical expertise. This study describes an approach for quantitative image analysis of microendoscopic images to identify neoplastic lesions in ...
Neil Parikh +11 more
openaire +4 more sources
Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. [PDF]
PLoS ONE, 2008 Barrett's esophagus is a premalignant condition whereby the normal stratified squamous esophageal epithelium undergoes a transdifferentiation program resulting in a simple columnar epithelium reminiscent of the small intestine.
Douglas B Stairs +7 more
doaj +1 more source
Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma [PDF]
, 2015 Author version made available in accordance with publisher policy.Abstract Background The poor prognosis and rising incidence of esophageal adenocarcinoma highlight the need for improved detection methods.
Bowen, Joanne M +12 more
core +1 more source
DINAMIC SCREENING OF PRECANCEROUS ESOPHAGUS USING MOLECULAR GENETIC ANALYSIS
Сибирский онкологический журнал, 2020 Introduction. Esophageal adenocarcinoma develops from areas of intestinal metaplasia in Barrett’s esophagus, similar to how intestinal metaplasia transforms into gastric adenocarcinomas in the stomach.
V. V. Anishchenko +5 more
doaj +1 more source
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022 Barrett’s esophagus (BE) is caused by metaplasia of squamous epithelium into columnar epithelium, mainly in the lower esophagus. Updates have been made in the etiology, diagnosis and treatment of BE since its first report as an ulcerative lesion in the ...
Yong Kang Lee
doaj +1 more source
Molecular biomarkers and ablative therapies for Barrett’s esophagus [PDF]
, 2012 Author version made available in accordance with the publisher's policy.Barrett’s esophagus is the major risk factor for esophageal adenocarcinoma. Endoscopic interventions which ablate Barrett’s esophagus mucosa lead to replacement with a new squamous ...
Chisolm, Jacob A +3 more
core +1 more source
LOW PREVALENCE OF BARRETT’S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL
Arquivos de Gastroenterologia, 2017 BACKGROUND: Barrett’s esophagus a complication of gastroesophageal reflux disease (GERD) is a precursor of esophageal adenocarcinoma. The incidence of esophageal adenocarcinoma has been increasing in most Western countries.
Diego Michelon DE CARLI +2 more
doaj +1 more source
Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies [PDF]
, 2005 Vascular endothelial growth factors ( VEGF)- A, - C and - D are members of the proangiogenic VEGF family of glycoproteins. VEGF-A is known to be the most important angiogenic factor under physiological and pathological conditions, while VEGF-C and VEGF-D
Ahn MJ +48 more
core +1 more source
Additional file 1: of NSAID use and somatic exomic mutations in Barrettâ s esophagus
, 2018 Supplemental Methods: Additional file 1 describes details of the study subjects, study design, exposure quantification methods, sample processing and sequencing methodologies, statistical methods for all analyses, and copy number/cnLOH calling methods. (DOCX 88 kb)
Galipeau, Patricia +10 more
openaire +1 more source
Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence
Endoscopy International Open, 2015 Background and study aims: It has been postulated that the endoscopic ablation of Barrett’s esophagus can lead to complete eradication of the disease.
Shreyas Saligram +12 more
doaj +1 more source